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BaCKGroUNd: Lynch syndrome is a disorder caused 
by mismatch repair gene mutations. Mutation carriers 
have a high risk of developing colorectal cancer. In 
patients with Lynch syndrome in whom colon cancer 
has been diagnosed, in general, subtotal colectomy 
instead of partial colectomy is recommended because of 
the substantial risk of metachronous colorectal cancer. 
However, the effect of more extensive surgery on quality 
of life and functional outcome is unknown.
oBJECtiVE: The aim of this study was to investigate 
quality of life and functional outcome in patients with 
Lynch syndrome after partial colectomy and subtotal 
colectomy.
dESiGN: This is a nationwide cross-sectional study in the 
Netherlands.
SEttiNGS: Two quality-of-life questionnaires (Short 
Form-36 and The European Organization for Research 
and Treatment of Cancer Colorectal Cancer-specific 
Quality of Life Questionnaire Module) and a functional 
outcome questionnaire (Colorectal Functional Outcome) 
were used.
PatiENtS: Patients with Lynch syndrome who 
underwent surgery for colon cancer were included.
MaiN oUtCoME MEaSUrES: The primary outcomes 
measured were quality of life and functional outcome.
rESUltS: Questionnaires were sent to 192 patients with 
Lynch syndrome who underwent surgery for colorectal 
cancer. A total of 136 patients returned the questionnaire 
(response rate, 71%). Eighteen patients with rectal 
cancer, 9 patients with a permanent ileostomy, and 5 
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patients with an IPAA were excluded. Fifty-one patients 
underwent partial colectomy, and 53 underwent subtotal 
colectomy. None of the scales of the Short Form-36 
survey showed a significant difference. Analysis of the 
Colorectal Functional Outcome questionnaire revealed 
that, after subtotal colectomy, patients have a significantly 
higher stool frequency (p  0.01) and a significantly 
higher score on stool-related aspects (p  0.06) and 
social impact (p  0.03). The European Organization for 
Research and Treatment of Cancer Colorectal Cancer-
specific Quality of Life Questionnaire Module presented 
more problems with defecation after subtotal colectomy 
(p  0.01).
liMitatioNS: Certain selection bias cannot be ruled out.
CoNClUSioNS: Although functional outcome is worse 
after subtotal colectomy than after partial colectomy, 
generic quality of life does not differ after the 2 types 
of surgery in Lynch syndrome. When discussing the 
options for surgery with the patient, all advantages and 
disadvantages of both surgical procedures, including 
quality of life and functional outcome, should be 
discussed.
KEY WordS: Lynch syndrome; Quality of life; Functional 
outcome; Colon cancer; Surgery.
Colorectal carcinoma (CRC) is one of the most com-mon cancers worldwide.1,2 In approximately 5% of all cases, CRC is associated with a highly penetrant 
dominant or recessive inherited syndrome. The most com-
mon of these is Lynch syndrome (hereditary nonpolyposis 
colorectal cancer).3 Lynch syndrome (LS) is an autosomal 
dominant disorder caused by a mutation in one of the 
mismatch repair genes.4,5 Mutation carriers have a lifetime 
risk of approximately 25% to 75% to develop CRC. In 
addition, they have an increased risk of developing endo-
metrial cancer and various other malignancies.4–6
Because of the high risk of developing CRC, gene 
mutation carriers are advised to participate in intensive 
colonoscopic surveillance programs. The aim of these pro-
grams is to detect and remove adenomatous polyps, the 
premalignant lesions of CRC, and to detect cancers at an 
early stage. Most authors recommend subtotal colectomy 
when CRC is diagnosed, especially in young patients be-
cause of the high risk of a metachronous CRC after par-
tial colectomy. Several studies reported that the risk of 
developing metachronous CRC varies between 22% and 
41%.7–9 We found a 10-year cumulative risk of developing 
CRC after partial colectomy of 16% in comparison with 
3% after subtotal colectomy.10 Moreover, with the use of a 
mathematical (Markov) model, we observed that subtotal 
colectomy was associated with a slightly increased life ex-
pectancy.11 In this study, the overall life expectancy gain of 
subtotal colectomy in comparison with hemicolectomy at 
ages 27, 47, and 67 was 2.3, 1, and 0.3 years, respectively. 
When CRC is diagnosed above the age of 60 years, partial 
colectomy appears to be justified, because the expected 
survival benefit is small.11,12
To date, there are no studies comparing quality of life 
(QoL) and functional outcome after both types of surgery 
in patients with LS. The question whether QoL differs 
between partial and subtotal colectomy is becoming more 
important because of the recently reported low risk of 
developing CRC while under surveillance.13 If a substan-
tial difference in QoL would exist, the recommendation 
for subtotal colectomy in young patients with CRC might 
be revised.
In addition, for adequate patient education, informa-
tion regarding functional outcome and QoL is essential. 
The aim of the present study, therefore, was to investigate 
QoL and functional outcome after partial colectomy and 
subtotal colectomy in patients with LS.
MEtHodS
Study design
This study was a nationwide cross-sectional study in the 
Netherlands to investigate whether patients with LS who 
underwent a subtotal colectomy have a different QoL 
and functional outcome in comparison with patients that 
underwent partial colectomy.
Study Population
The study population consisted of 288 patients with LS 
living in the Netherlands who underwent a partial or sub-
total colectomy for CRC and were registered at the Dutch 
Lynch Syndrome Registry.
Patients were considered to have LS if they were 
 proven, obligate, or probably gene carriers. untested per-
sons from LS families who developed CRC under the age 
of 50 were defined as probably gene carriers. Patients were 
excluded if they underwent surgery less than 1 year before 
March 15, 2010, the starting date of the study. Metastat-
ic disease was also an exclusion criterion. The study was 
approved by the university Medical Center St. Radboud 
Nijmegen Medical Ethical Committee.
Procedure
Patients with LS registered at the Dutch Lynch Syndrome 
Registry who underwent a colectomy for CRC were iden-
tified. This national registry for families with hereditary 
CRC was established in the Netherlands in 1987. The reg-
istry had 3 objectives: 1) to promote surveillance in LS 
families; 2) to guarantee the continuity of the surveillance 
program; and 3) to promote research in this field. The 
methods and approach of the registry have been described 
elsewhere.14 Subsequently, the specialists were asked for 
DISEASES OF THE COLON & RECTuM VOLuME 55: 6 (2012) 655
permission to contact their patients. When their specialist 
approved, patients were sent 3 validated questionnaires 
concerning QoL and functional outcome. From all re-
spondents, patients with rectal cancer, a permanent ileo-
stomy, or an IPAA were excluded, because these types of 
surgery are very different in comparison with colon sur-
gery alone. The remaining respondents were subsequently 
classified into 2 groups based on the type of surgery they 
had undergone. The first group consisted of patients who 
had undergone a partial colectomy. Partial colectomy 
was defined as a segmental resection, ileocecal resection, 
right or left hemicolectomy, transversectomy, or sigmoid 
resection. The second group included patients that un-
derwent a subtotal colectomy. Patients were thought to 
have undergone a subtotal colectomy if the surgeon had 
documented the procedure as such, or if at least the to-
tal colon, with the exception of the rectum and, in many 
patients, also a part of the sigmoid, was resected. Patients 
who had more than one resection belonged to the partial 
colectomy group when the level of the anastomosis was 
above the sigmoid and if more than 50 cm of colorectum 
was still in situ.
instruments
Three questionnaires were sent to the patients. To inves-
tigate generic QoL, the Short Form-36 (SF-36) health 
survey was sent. To assess disease-specific QoL, the Euro-
pean Organization for Research and Treatment of Cancer 
Colorectal Cancer-specific Quality of Life Questionnaire 
Module (EORTC QLQ CR-38) was sent. To obtain infor-
mation about bowel function, the Colorectal Functional 
Outcome (COREFO) questionnaire was used.
SF-36. The SF-36 is one of the most used generic instru-
ments about the QoL. The SF-36 consists of 36 multi-
ple-choice questions. These questions are divided into 
8 domains: physical functioning, role limitations due to 
physical health problems, bodily pain, general health per-
ceptions, vitality, social functioning, role limitations due 
to emotional problems, and general mental health. The 
raw data are converted into a scale running from 0 to 100. 
A higher score indicates a higher level of functioning or 
well-being.15,16
EortC QlQ Cr-38. EORTC QLQ CR-38 is a specific in-
strument to measure QoL. It is developed for patients 
with CRC. This questionnaire consists of 38 multiple-
choice questions. Nineteen questions are answered by 
subgroups: namely by female or male patients or by pa-
tients with or without a stoma. The EORTC QLQ CR-38 
consists of 2 function domains (body image and sexual 
function) and 7 symptom domains (micturition prob-
lems, GI tract symptoms, chemotherapy side effects, def-
ecation problems, stoma-related problems, and male and 
female sexual problems). Moreover, 3 single items are part 
of the questionnaire: sexual enjoyment, future perspective, 
and weight loss. The raw scores are summed into domains 
and rescaled from 0 to 100. A higher score indicates bet-
ter functioning for all functioning scales and for the single 
items, sexual enjoyment and future perspective. A higher 
score at the symptom scales and the single item weight loss 
corresponds with a higher level of symptomatology.17,18
CorEFo. The COREFO questionnaire is a reliable and val-
id instrument consisting of 27 multiple-choice questions 
to evaluate the functional outcome after colorectal surgery. 
This questionnaire is divided into 5 scales: incontinence, 
social impact, frequency, defecation-related aspects, and 
use of drugs. The data are converted into a score of 0 to 
100; a higher score indicates a worse functional outcome.19
Statistical analysis
The statistical analysis was performed with SPSS version 
16.0. Student t tests were used for group comparisons. Pro-
portions were compared by χ2 tests. The Mann-Whitney U 
test was used for comparing follow-up. p values less than 
0.05 were considered statistically significant. Incomplete 
questionnaires were handled in accordance with the stan-
dards in the user manuals of the questionnaires.
rESUltS
A total of 288 living patients with LS who had under-
gone a colectomy because of CRC were identified at the 
Dutch Lynch Syndrome Registry. Six of them died short-
ly before the start of the survey. For 86 patients, the spe-
cialist did not respond to our invitation letter or did not 
allow us to approach their patients. Three patients had 
moved and their new address was unknown by the clos-
ing date of the study. One patient was excluded because 
of metastatic disease. In total, 192 patients were invited. 
One hundred thirty-six questionnaires were returned. 
The response rate was 71%. None of these patients un-
derwent surgery less than 1 year before the starting date 
of the study.
Nonresponders were not different from responders 
with respect to age, sex, type of surgery, pathological stage 
of CRC, and type of the mismatch repair mutation. Based 
on the type of surgery 18 patients with rectal cancer, 9 
patients with a permanent ileostomy, and 5 patients with 
an IPAA were excluded. Fifty-one patients had undergone 
a partial colectomy and 53 patients a subtotal colectomy 
(Fig. 1). The mean time period between the surgical pro-
cedure and time of survey was 11.6 years (range, 1.3–32.3 
years). In the subtotal colectomy group, the mean length 
of colorectum in situ measured at colonoscopy was 23 cm 
(range, 5–50 cm). Groups were comparable with respect 
to most clinical features (Table 1). However, patients in 
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the partial colectomy group had a significantly longer 
follow-up.
Qol and Functional outcome
The results of the SF-36 are shown in Figure 2. No sig-
nificant differences were found between both groups with 
regard to generic QoL, as measured by the SF-36. Figure 
3 demonstrates the results of the EORTC QLQ CR-38. 
Patients in the subtotal colectomy group had a significantly 
higher score on defecation problems (p  0.01). Patients 
in the partial colectomy group had a significantly higher 
score on the “male sexual problems” scale (p  0.02).
Figure 4 shows the results of the COREFO question-
naire. Patients in the subtotal colectomy group reported 
a significantly higher stool frequency (p  0.01) and had 
a significantly higher score on the scales social impact 
(p  0.03) and stool-related aspects (p  0.06).
diSCUSSioN
This cross-sectional study demonstrates that generic QoL 
does not differ after subtotal colectomy and partial colec-
tomy in patients with LS. After subtotal colectomy, pa-
tients have a worse functional outcome in terms of stool 
frequency, stool-related aspects, and social impact in com-
parison with patients who underwent a partial colectomy.
To our knowledge, this is the first study that evaluated 
the QoL and bowel function after colectomy in patients 
with LS. However, similar studies have been published 
for other patient populations. you et al20 retrospectively 
reviewed 321 resections. Both bowel function and QoL 
after subtotal colectomy were inferior to bowel function 
and QoL after segmental colectomy. A possible explana-
tion for the different outcome in QoL in comparison with 
our study might be differences in patient demographics 
and indication for surgery. The most common indication 
Patients registered at Dutch Lynch
Syndrome Registry
n = 288
Questionnaires sent
n = 192
Returned questionnaires
n = 136
Partial colectomy
n = 51
Subtotal colectomy
n = 53
Patients excluded
– No response or permission
 from specialist n = 86
– Dead n = 6
– Unknown address n = 3
– Metastatic disease n = 1
Patients excluded
– Rectal cancer n = 18
– Permanent ileostomy n = 9
– IPAA n = 5
Included patients
n = 104
FIGURE 1. Study design.
TABLE 1. Clinical data
Partial colectomy  
(n  51)
(Sub)total 
colectomy  
( n  53)
pn % n %
Sex 0.44a
 Male 25 49 30 57
 Female 26 51 23 43
Mutation type 0.38a
 MLH1 23 45 25 47
 MSH2 19 37 24 45
 MSH6 8 16 4 8
 Unknown 1 2
Mutation status 0.61a
 Proven gene carrier 42 82 41 77
 Obligate gene carrier 3 6 4 8
 Probably gene carrier 6 12 8 15
Stadium carcinoma 0.11a
 Dukes A  B 38 75 46 87
 Dukes C 13 25 7 13
More resections 0.28a
 Yes 5 10 9 17
 No 46 90 44 83
Age, y, mean (SD) 59.0 11.9 58.0 10.0 0.64b
Follow-up after surgery, 
y, median  
(IQR 25–75)
12.7 8.5–18.7 9.2 4.2–12.0 0.01c
IQR  interquartile range. Quartile 25 and 75.
aχ2 test.
bStudent t test.
cMann-Whitney U test.
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for extended resection was multiple polyps, particularly 
in younger patients with previous resections, whereas 
segmental resections were primarily performed in older 
women with CRC. Moreover, possibly not all patients 
reached the plateau in their functional outcome, because 
patients were surveyed at various time intervals (includ-
ing less than 1 year) after surgery. Clinical experience and 
previous studies suggest that it takes 6 to 12 months for 
bowel function to stabilize postoperatively. In addition, 
right- sided colonic resections resulting in ileocolonic 
anastomosis were excluded from you’s study. This surgical 
procedure is common especially in LS. Because of all these 
differences, it is difficult to compare these results with our 
study.
The SCOTIA group prospectively compared subto-
tal colectomy with segmental resection in patients with 
malignant left-sided CRC.21 No significant difference in 
general health status was found, which corresponds to our 
results.
Subtotal colectomy seems to have a worse functional 
outcome and a higher social impact than partial colec-
tomy, as measured by the COREFO. Although functional 
outcome is worse after subtotal colectomy, no difference 
in social functioning and generic QoL as measured by 
the SF-36 seems to exist after both types of surgery. This 
suggests that a worse functional outcome cannot be 
extrapolated to a worse QoL. Ko et al22 also documented 
that better functional results do not necessarily equate 
to better QoL in patients with familial adenomatous 
polyposis.
It is possible that general QoL does not differ between 
subtotal colectomy and partial colectomy in patients with 
LS because, after a subtotal colectomy, LS patients are less 
anxious about developing a metachronous CRC. Also, 
only regular sigmoidoscopy is needed for surveillance, 
and patients less often need secondary surgery. Patients 
also possibly adapt and become accustomed to the new 
situation and functional outcome after a long follow-up. 
Another explanation might be that the SF-36 is not sensi-
tive enough to detect subtle differences in QoL determined 
by minor operative resection extents.
QoL scores of the subscales of the SF-36, in general, 
were comparable to normal scores of the Dutch national 
population. However, on the subscale “mental health,” 
patients seemed to score higher in comparison with the 
Dutch population.15 A possible explanation might be that 
some cancer survivors report posttraumatic growth. A 
Type of surgery
Partial colectomy
(Sub)total colectomy
General health perceptions
Vitality
Role emotional
Mental health
Social functioning
Bodily pain
Role physical
Physical functioning
0 20 40
Mean
60 80 100
FIGURE 2. Results SF-36. A higher score represents a higher level of 
functioning. Error bars, 61 SD. SF-36  Short Form-36 health survey.
Type of surgery
(a) (b)
Partial colectomy
(Sub)total colectomy
Sexual enjoyment
Sexual function
Future perspective
Body image
0 20 40
Mean
60 80 100
Type of surgery
Partial colectomy
(Sub)total colectomy
Defecation problems
Female sexual problems
Male sexual problems
Sexual enjoyment
Chemotherapy side eects
Weight loss
GI-tract problems
Micturition problems
Stoma-related problems
0 20 40
Mean
60 80 100
FIGURE 3. Results EORTC QLQ CR-38. A, Functional scales and single items (sexual enjoyment and future perspective): A higher score 
indicates better functioning. Error bars, 61 SD. B, Symptom scales and the single item weight loss: A higher score indicates a higher level of 
symptomatology. Error bars, 61 SD. EORTC QLQ CR-38  European Organization for Research and Treatment of Cancer Colorectal Cancer-
specific Quality of Life Questionnaire Module.
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younger age at diagnosis, as is the case in LS, is associated 
with greater posttraumatic growth.23,24
An unexpected finding of this study was that, in com-
parison with subtotal colectomy, male patients report sig-
nificantly more sexual problems after partial colectomy. 
We do not have an explanation for this observation.
Several limitations of the current study should be 
noted. First, we cannot rule out certain selection bias. The 
present study was a cross-sectional study to examine QoL 
in patients with LS after colectomy, which might have 
lead to selection bias by selective nonresponse. However, 
responders did not differ from nonresponders in terms 
of objective criteria, and the response rate was relatively 
high (71%). Hence, the influence of selective nonre-
sponse is probably small. Second, selection bias could have 
occurred by selection of patients with little comorbidity 
for subtotal colectomy instead of partial colectomy. How-
ever, the influence of this is probably low, because CRC 
in LS patients generally occurs at a relatively young age. 
Because we included a relatively large group of patients 
with similar ages in both groups, we assumed similar 
comorbidity. However, theoretically, the 2 groups could 
have differed in comorbidity.
Another limitation might be the classification of 
people with multiple resections in the partial or subtotal 
group. However, subanalysis of patients with only 1 resec-
tion demonstrated no differences. Ideally, QoL should be 
evaluated at different time periods. Therefore, we suggest 
future studies with a prospective design with measure-
ments before and after surgery.
What are the implications of this study concerning the 
management of screen-detected CRC in LS? Owing to the 
many factors that should be considered in the decision-
making process, it is difficult to provide a general recom-
mendation for all patients.25 Subtotal colectomy reduces 
the risk of metachronous CRC in comparison with partial 
colectomy and subsequently leads to a slightly increased 
life expectancy. Contemporaneously, generic QoL does not 
differ after the 2 types of surgery. Therefore, we consider 
subtotal colectomy as the treatment of choice in young 
patients (eg, 60 years) with CRC detected under surveil-
lance. Obviously, all advantages and disadvantages of both 
surgical procedures should be discussed with the patient.
CoNClUSioN
Although functional outcome is worse after subtotal 
colectomy than after partial colectomy, generic QoL does 
not differ after the 2 types of surgery in patients with LS. 
Patients should be informed about possible differences in 
functional outcome.
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